PG vs TXG · P/E 25, rev $84.28B vs rev $610.8M
Procter & Gamble Company (PG) versus 10X Genomics Inc (TXG) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported TXG revenue for 2024-12-31 was $610.8M. Net income was -$182.6M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. TXG currently screens at market cap $4.08B.
PG currently screens at market cap $373.53B and trailing P/E 25.3. TXG currently screens at market cap $4.08B.
Not investment advice. Open the PG and TXG stock pages for the full models.
Not investment advice.